[1,2,4] TRIAZOLO [1,5-A] PYRIDINE DERIVATIVE AND CRYSTALLINE FORM THEREOF

Title:

[1,2,4] TRIAZOLO [1,5-A] PYRIDINE DERIVATIVE AND CRYSTALLINE FORM THEREOF

Document Type and Number:

WIPO Patent Application WO/2018/000549

Kind Code:

A1

Abstract:

A [1,2,4] triazolo [1,5-a] pyridine derivative as shown in formula (I) and a crystalline form thereof. The compound has a significant inhibitory effect against tumor cells, is applicable in preventing and/or treating tumor-related diseases, in particular lung cancer, and has broad application prospects.

More Like This:

JP6133291	3, 4-pyrazolo [c] pyridine compound and directions for use
JP2000186039	MEDICAMENT COMPOSITION INCLUDING GONADOTROPIN-RELEASING HORMONE ANTAGONIST
WO/2019/227007	TRICYCLIC HETEROCYCLIC COMPOUNDS AS STING ACTIVATORS

Inventors:

LI WEIMIN (CN)
HE YANG (CN)
ZHANG LI (CN)
CHEN BOJIANG (CN)
QIU ZHIXIN (CN)

Application Number:

PCT/CN2016/095503

Publication Date:

January 04, 2018

Filing Date:

August 16, 2016

Export Citation:

Click for automatic bibliography generation Help

Assignee:

WEST CHINA HOSPITAL SICHUAN UNIV (CN)

International Classes:

C07D471/04; A61K31/5377; A61P35/00

Domestic Patent References:

WO2008065198A1	2008-06-05
WO2009047514A1	2009-04-16

Foreign References:

CN102131390A	2011-07-20
CN101535307A	2009-09-16
CN102203093A	2011-09-28

Attorney, Agent or Firm:

GAOYUNG INTELLECTUAL PROPERTY AGENCY (GENERAL PARTNERSHIP) (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: INTELLIGENT STAMP WITH LOCKING MECHANISM

Next Patent: PYRAZOLO [3,4-D] PYRIMIDINE DERIVATIVE